<DOC>
	<DOCNO>NCT01590108</DOCNO>
	<brief_summary>The purpose study - Determine blood peptide level investigate tissue gradient apelin patient idiopathic pulmonary arterial hypertension healthy volunteer . - Evaluate effect exogenous apelin infusion exercise performance healthy volunteer patient idiopathic pulmonary arterial hypertension .</brief_summary>
	<brief_title>The Study Apelin-APJ System Pulmonary Hypertension Patients Healthy Subjects</brief_title>
	<detailed_description>Idiopathic pulmonary arterial hypertension remain enigma physician diagnosis treatment . Existing biomarkers , tissue characteristic definite treatment restrict . There many evidence suggest Apelin-APJ system associate Idiopathic Pulmonary Arterial Hypertension ( IPAH ) . A comprehensive characterise circulate peptide level investigate tissue gradient apelin patient idiopathic pulmonary arterial hypertension healthy volunteer might provide important information pathophysiologic process diagnostic marker . In addition , first time human study assessment effect exogenous apelin infusion exercise performance healthy volunteer patient idiopathic pulmonary arterial hypertension essential confirm whether relevance animal model clinical subject .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<criteria>Inclusion Criteria Control group : Structurally normal heart 2D Echocardiography Pulmonary artery pressure &lt; 25mmHg Tricuspid velocity &lt; 2.5ms1 Inclusion Criteria Treatment group : Clinical diagnosis Pulmonary arterial hypertension idiopathic , associate anorexigens associate connective tissue disease familial Able give inform consent Mean pulmonary artery pressure &gt; 25mmHg , pulmonary capillary wedge pressure &lt; 15mmHg , normal reduce cardiac output . Exclusion Criteria ALL group : Bleeding diathesis ( PT &gt; 14 sec aPTT &gt; 40 sec ) Pregnancy , woman child bear potential adequate contraception Renal hepatic failure Severe valvular heart disease Left ventricular dysfunction ( LVEF &lt; 40 ) Chronic lung disease Malignant arrhythmias Chronic thromboembolic disease</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Idiopathic Pulmonary Arterial Hypertension</keyword>
	<keyword>IPAH</keyword>
	<keyword>Apelin</keyword>
	<keyword>APJ receptor</keyword>
</DOC>